Proteome Sciences PLC Director/PDMR Shareholding (6389I)

TIDMPRM

RNS Number : 6389I

Proteome Sciences PLC

22 March 2018

Proteome Sciences plc

("Proteome Sciences" or the "Company")

Director/PDMR Shareholding

The Company announces that on 21 March 2018 Roger McDowell, a Non-Executive Director of the Company, sold 500,000 ordinary shares of 1 pence each ("Ordinary Shares") at a price of 3 pence per Ordinary Share and bought, into his SIPP, 500,000 Ordinary Shares at a price of 3.006 pence per Ordinary Share (the "Transfer").

Following the Transfer, Mr McDowell's beneficial interest in the Company remains at 2,500,000 Ordinary Shares representing approximately 0.91% of the issued share capital of the Company.

 
For further information: 
 Proteome Sciences plc 
Jeremy Haigh, Chief Executive Officer Tel: [phone] 
Ian Pike, Chief Scientific Officer 
Stefan Fuhrman, Finance Director 
 
  finnCap Limited (Nominated Adviser/Broker) 
Geoff Nash/James Thompson                            Tel: [phone] 
Tony Quirke (broking) 
 
 

About Proteome Sciences plc. (www.proteomics.com):

Proteome Sciences is a leader in applied proteomics offering high sensitivity, proprietary technologies and workflows for mapping cell signalling pathways (SysQuant(R) ) and for the discovery, validation and assay development of protein biomarkers (TMTcalibrator(TM) ). The company has its headquarters in London, UK, with laboratory facilities in Frankfurt, Germany from where the PS Biomarker Services(TM) division provides outsourced proteomics services and proprietary biomarker assays to biopharmaceutical and diagnostics companies and to academia.

Proteome Sciences has patented a number of novel protein biomarkers for diagnostic and treatment applications in important areas of human therapeutics such as cancer, stroke and Alzheimer's disease, and these are available for license.

 
1.  Details of the person discharging managerial responsibilities / person closely associated 
a)  Name                                                      Roger McDowell 
2.  Reason for the Notification 
a)  Position/status                                           Non-Executive Director 
b)  Initial notification/Amendment                            Initial notification 
3.  Details of the issuer, emission allowance market participant, auction platform, auctioneer 
     or auction monitor 
a)  Name                                                      Proteome Sciences plc 
b)  LEI                                                       213800Q62ICXANKU2986 
4.  Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
     each type of transaction; (iii) each date; and (iv) each place where transactions have been 
     conducted 
a)  Description of the Financial instrument, type of          Ordinary Shares of 1p each 
    instrument 
    Identification code                                       GB0003104196 
b)  Nature of the transaction                                 Purchase and sale of shares 
c)  Price(s) and volume(s)                                    500,000 Ordinary Shares bought at 3.006p per Ordinary 
                                                              Share 
                                                              500,000 Ordinary Shares sold at 3.000p per Ordinary 
                                                              Share 
d)  Aggregated information:                                   500,000 Ordinary Shares bought at 3.006p per Ordinary 
     -- Aggregated volume                                     Share 
     -- Price                                                 500,000 Ordinary Shares sold at 3.000p per Ordinary 
                                                              Share 
e)  Date of the transaction                                   21 March 2018 
f)  Place of the transaction                                  London Stock Exchange, AIM Market (XLON) 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHSEMFDEFASEFD

(END) Dow Jones Newswires

March 22, 2018 09:18 ET (13:18 GMT)